Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

First clinical results with 90Y-DOTATOC indicate antitumor efficacy, some safety problems

Jan. 19, 2000

CKD-731: new fumagillin analogue shows potential as antiangiogenic agent

Jan. 19, 2000

Distamycin derivatives in development at Pharmacia & Upjohn

Jan. 19, 2000

Phase I trial shows excellent safety profile for NeoRx's STR agent

Jan. 19, 2000

Broad patent issued to IntraBiotics covering its protegrin analogues

Jan. 18, 2000

Discovery and use of E6-binding polypeptides for suppressing tumor growth

Jan. 18, 2000

The Liposome Company submits additional Evacet data to FDA

Jan. 18, 2000

SuperGen licenses VTA technology from Techniclone

Jan. 18, 2000

ISIS-5132 reduces target RNA levels in human study

Jan. 18, 2000

M.D. Anderson Cancer Center to guide arglabin preclinical studies

Jan. 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...